Thermo Fisher Spent $314M on Two Acquisitions in Q1; Settled IP Suits With Roche 454, Illumina

May 11, 2017

|

NEW YORK (GenomeWeb) – Thermo Fisher Scientific disclosed in a filing yesterday with the US Securities and Exchange Commission the purchase price for its recent acquisitions of Core Informatics and Finesse Solutions, as well as the settlement earlier this year of three patent lawsuits involving DNA sequencing technology from Roche 454 Life Sciences and Illumina.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

The Preliminary Investigation

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn Dies

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Similar, But Not Quite the Same

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

This Week in PNAS

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.

Main menu